Clinical Trial Update: Whole Body Dynamic 68Ga-DOTATOC PET/CT in Neuroendocrine Tumors

View source ↗

Summary

This document reports the completion of a clinical trial evaluating whole-body dynamic PET/CT imaging with 68Ga-DOTATOC in neuroendocrine tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumors

Drugs mentioned

• 68Ga-DOTATOC (DOTATOC)

Snippet

Sponsor: University Hospital, Brest | Conditions: Neuroendocrine Tumors | Status: COMPLETED